EGF Receptor (EGF-R) Analysis in Endometrial Carcinomas

  • Thomas Bauknecht
Part of the AGO Arbeitsgemeinschaft für Gynäkologische Onkologie book series (AGO)


A better understanding of cell growth and differentiation began with the detection of the proto-oncogenes [1]. In the process of tumor development and progression a modification of the structure and the function of these genes probably take place which are detected molecular-chemically as activated oncogenes [2].


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Garrett C (1986) Oncogenes. Clin Chim Acta 156: 1–40PubMedCrossRefGoogle Scholar
  2. 2.
    Merkel DE, McGuire WL (1988) Oncogenes and cancer prognosis. In: Devita VT Jr, Hellmann S, Rosenberg eds: Important advances in oncology. Philadelphia: Lippincott JB, pp 103–117Google Scholar
  3. 3.
    Downward J, Yarden Y, Mayes E, Scrace G, Totty N et al (1984) Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences.Nature 307: 521–527PubMedCrossRefGoogle Scholar
  4. 4.
    Carpenter G and Cohen S (1979) Epidermal growth factor. Ann Rev Biochem 48: 193–216PubMedCrossRefGoogle Scholar
  5. 5.
    Massaque J (1983) Epidermal growth factor like transforming growth factor. J Biol Chem 258: 13606–13614Google Scholar
  6. 6.
    Derynck R (1986) Transforming growth factor structure and biological activities. J Cell Biochem 32: 293–304PubMedCrossRefGoogle Scholar
  7. 7.
    Sainsbury J, Farndorn J, Needham G, Malcolm A, and Harris A (1987) Epidermal growth factor receptor status as predictor for early recurrence of and death from breast cancer. Lancet I: 1398–1402Google Scholar
  8. 8.
    Bauknecht T, Runge M, Schwall M, and Pfleiderer A (1988) Occurrence of epidermal growth factor receptor in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol Oncol 29:147–159PubMedCrossRefGoogle Scholar
  9. 9.
    Bauknecht T, Janz I, Kohler M, and Pfleiderer A (1989) Human ovarian carcinomas: Correlation of malignancy and survival with the expression of epidermal growth factor receptor and EGF like factor. Med Oncol Pharmacother 6: 121–127Google Scholar
  10. 10.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T (1989) The expression of epidermal growth factor receptor, EGF like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 9: 1537–1548PubMedGoogle Scholar
  11. 11.
    Hunts I, Ueda M, Ozawa S, Abe O, Pastan I and Shimizu N (1985) Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn. J. Cancer Res 76: 663–666PubMedGoogle Scholar
  12. 12.
    Yasui M, Sumgoski H, Hata I, Kameda I, Ochiai A, Ito H, and Tahara E (1988) Expression of epidermal growth factor receptor in human gastric and colonic carcinoma. Cancer Res 48: 137–141PubMedGoogle Scholar
  13. 13.
    Keski-Oja J, Leof E, Lyons R, Coffey R, Moses H (1987) Transforming growth factors and control of neoplastic cell growth. J Cell Biochem 33: 95–107PubMedCrossRefGoogle Scholar
  14. 14.
    Kistner RW (1979) Adenocarcinoma. In: Gynecologic Principles and Practise, Chicago: Year Book Medical Publisher, Inc., pp 255–272Google Scholar
  15. 15.
    Aalders JG, Abeler V, and Kolstad P (1984) Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 17: 64–74PubMedCrossRefGoogle Scholar
  16. 16.
    Chambers SK, Kapp DS, Peschel RE, Lawrence R, Mernio M, Kohoru EI, Schwarz PE (1987) Prognostic factors and sites of failure in Figo stage I, grade 3 endometrial cancer. Gynocol Oncol 27: 180–188CrossRefGoogle Scholar
  17. 17.
    Grisgby PW, Perez CA, Kushe RR, Kao MS, and Galakatos AE (1987) Results of therapy, analysis of failures and prognostic factors for clinical and pathological stage III adenocarcinoma of the endometrium. Gynocol Oncol 27: 44–57CrossRefGoogle Scholar
  18. 18.
    Goff BA, and Rice LW (1990) Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 38: 46–48PubMedCrossRefGoogle Scholar
  19. 19.
    Kleine W, Maier T, Geyer H, and Pfleiderer A (1990) Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecol Oncol 38: 59–65PubMedCrossRefGoogle Scholar
  20. 20.
    Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma: A highly malignant form of endometrial carcinoma. Am J Surg Pathol 6: 93–108PubMedCrossRefGoogle Scholar
  21. 21.
    Sutton GP, Brill L, Michael H, Stehmann FB, Ehrlich CE (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27: 294–304PubMedCrossRefGoogle Scholar
  22. 22.
    Sorbe B, Risberg B, and Frankendal B (1990) DNA ploidy, morphometry and nuclear grade as prognostic factors in endometrial carcinoma. Gynecol Oncol 38: 22–27PubMedCrossRefGoogle Scholar
  23. 23.
    Friedlander M, Hedley DW, Taylor I (1984) Clinical and biological significance of aneuploidy in human tumors. J. Clin. Pathol. 37: 961–974Google Scholar
  24. 24.
    TSOU KC, Hong DH, Varello MA et al. (1985) Flow cytometric DNA and 5’nucleotide phosphodiesterase in endometrium. Cancer 56: 2340–2347CrossRefGoogle Scholar
  25. 25.
    Sasano H, Comeford J, Wilkinson D, Schwartz A, Garrett C (1990) Serous papillary adenocarcinoma of the endometrium: Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Cancer 65: 1545–1551PubMedCrossRefGoogle Scholar
  26. 26.
    Bauknecht T, Rau B, Meerpohl HG, Pfleiderer A (1984) The prognostic value of the presence of epidermal growth factor receptor in ovarian carcinomas. Tumor Diagnostik Therapie 5: 62–66Google Scholar
  27. 27.
    Wittmaack FM, Schwörer D, Wintzer HO, von Kleist S, Pfleiderer A, Bauknecht T (1988) The immunohistochemical investigation of epidermal growth factor receptor in various gynecological tumors. IJIPP 1: 139–147Google Scholar
  28. 28.
    Bauknecht T, Kohler M, Janz I, Pfleiderer A (1989) The occurrence of epidermal growth factor receptor and the characterisation of EGF like factors in human ovarian, endometrial, cervical and breast cancer. J Cancer Res Clin Oncol 115: 193–199PubMedCrossRefGoogle Scholar
  29. 29.
    Bauknecht T, Gross G, Hagedorn M (1985) Epidermal growth factor receptor in different skin tumors. Dermatologica 171: 16–20PubMedCrossRefGoogle Scholar
  30. 30.
    Veale D, Marsh C, Ashcroft T, Harris A (1985) Epidermal growth factor receptor in non-small cell lung cancer. Br J Cancer 52: 441Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Thomas Bauknecht

There are no affiliations available

Personalised recommendations